Adhikari, N., Amin, S.A., Saha, A. and Jha, T. (2017) Combating Breast Cancer with Non-Steroidal Aromatase Inhibitors (NSAIs): Understanding the Chemico-Biological Interactions through Comparative SAR/QSAR Study. European Journal of Medicinal Chemistry, 137, 365-438.
https://doi.org/10.1016/j.ejmech.2017.05.041

has been cited by the following article:

• TITLE: Breast Cancer MCF-7 Cell Spheroid Culture for Drug Discovery and Development

  AUTHORS: Guangping Chen, William Liu, Bingfang Yan

  KEYWORDS: MCF-7 Cell, Spheroid Culture, 3D Cell Culture, Estrogen-Dependent Breast Cancer, Cancer Drug Development, Personalized Cancer Drug Development

  JOURNAL NAME: Journal of Cancer Therapy, Vol.13 No.3, March 9, 2022

  ABSTRACT: In vitro 3D cancer spheroids (tumoroids) exhibit a drug resistance profile similar to that found in solid tumors. 3D spheroid culture methods recreate more physiologically relevant microenvironments for cells. Therefore, these models are more appropriate for cancer drug screening. We have recently developed a protocol for MCF-7 cell spheroid culture, and used this method to test the effects of different types of drugs on this estrogen-dependent breast cancer cell spheroid. Our results demonstrated that MCF-7 cells can grow spheroid in medium using a low attachment plate. We managed to grow one spheroid in each well, and the spheroid can grow over a month, the size of the spheroid can grow over a hundred times in volume. Our targeted drug experimental results suggest that estrogen sulfotransferase, steroid sulfatase, and G protein-coupled estrogen receptor may play critical roles in MCF-7 cell spheroid growth, while estrogen receptors α and β may not play an essential role in MCF-7 spheroid growth. Organoids are the miniatures of in vivo tissues and reiterate the in vivo microenvironment of a specific organ, best fit for the in vitro studies of diseases and drug development. Tumoroid, developed from cancer cell lines or patients’ tumor tissue, is the best in vitro model of in vivo tumors. 3D spheroid technology will be the best future method for drug development of cancers and other diseases. Our reported method can be developed clinically to develop personalized drugs when the patient’s tumor tissues are used to develop a spheroid culture for drug screening.